CVD mortality similar with diuretic, ACE inhibitor, or calcium channel blocker
Dec 04, 2023
Those randomly assigned to receive ACE inhibitor had an increased risks for stroke mortality and fatal and nonfatal hospitalized stroke versus the diuretic group.
High-intensity statins underused with atherosclerotic cardiovascular disease
Sep 19, 2023
The authors say that the findings show gaps between practice and guideline-based care.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Statin initiation cuts mortality in older adults with chronic kidney disease
Jan 05, 2024
The findings were seen among older adults with stage 3 to 4 disease with no prior atherosclerotic cardiovascular disease.
Statin use increased from 1999-2000 to 2013-2014, then plateaued
Dec 04, 2023
No change was seen in the proportion using statins from 2013-2014 to 2017-2018 for those with diabetes and with ASCVD risk greater than 20%.
Risk for dementia reduced in association with antihypertensive use
Sep 13, 2023
An individual patient data meta-analysis shows increased risk for dementia for those with untreated hypertension.
AI may be useful in polypharmacy management
Apr 24, 2024
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.